Clinical Trial Detail

NCT ID NCT01058707
Title Dose Escalation Study of MLN0128 in Subjects With Advanced Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements no
Sponsors Millennium Pharmaceuticals, Inc.
Indications

Advanced Solid Tumor

Therapies

Sapanisertib

Age Groups: adult

No variant requirements are available.